Journal of Cancer Therapeutics & Research

Journal of Cancer Therapeutics & Research

ISSN 2049-7962
Short report

New York state health care provider participation in clinical trials: a brief report

Pathu Sriphanlop1, Danielle M. Crookes1, Karen Demairo2, Darryl Somayaji3, Maureen Killackey4, Anita McFarlane5, Jean LePere6 and Lina Jandorf1*

*Corresponding author: Lina Jandorf

1. Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, USA.

Author Affiliations

2. The Leukemia & Lymphoma Society, Long Island 1324 Motor Parkway Suite, Hauppauge, New York, USA.

3. Roswell Park Cancer Institute, Elm and Carlton Streets Buffalo, New York, USA.

4. Cornell Weill Medical College, York Avenue, New York, USA.

5. The Greater New York City Affiliate of Susan G. Komen for the Cure 470 Seventh Avenue, New York, USA.

6. Memorial Sloan-Kettering Cancer Center, York Avenue New York, USA.


Although health care providers are integral to the recruitment and enrollment of cancer patients in clinical trials, there is limited literature which has explored the differences between personal and practice characteristics of providers who participate and do not participate in clinical trials. Because little is known about these differences, this exploratory study sought to better understand the perceived barriers to participation among New York State providers. One hundred health care providers responded to the online survey. Respondents were predominantly male, between the ages of 50 and 64, White, have practiced for more than 20 years, and spoke only English. About half have conducted or been involved in a clinical trial. More than half reported that there are barriers to their participation in clinical research including time constraints, personnel needs, infrastructural needs, and a lack of access. While more research, with a larger sample is needed, this study provides evidence to the many of barriers providers face when considering their participation in clinical trials, with infrastructure being the most major. Findings suggest that infrastructural and personnel support could potentially increase clinical trial participation by health care providers.

Keywords: Clinical trials, health care providers, cancer

ISSN 2049-7962
Volume 5
Abstract Download